Cargando…

Clinical evidence regarding factors linking metabolic abnormal obesity to pancreatic β‐cell dysfunction

Detalles Bibliográficos
Autor principal:	Watada, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	JDI Updates
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378415/ https://www.ncbi.nlm.nih.gov/pubmed/32248633 http://dx.doi.org/10.1111/jdi.13264

Ejemplares similares

Obesity, metabolic syndrome and bariatric surgery: A narrative review
por: Jia, Weiping
Publicado: (2020)

New perspectives on insulin therapy
por: Araki, Eiichi, et al.
Publicado: (2020)

Recent evidence in the etiology and treatment for diabetic kidney disease
por: Shikata, Kenichi
Publicado: (2020)

Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
por: Lin, Kuan‐Yu, et al.
Publicado: (2021)

Impaired insulin secretion and related factors in East Asian individuals
por: Nakamura, Akinobu, et al.
Publicado: (2021)

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
por: Hosokawa, Yusei, et al.
Publicado: (2020)

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia
por: Seino, Yusuke, et al.
Publicado: (2019)

The journey to understanding incretin systems: Theory, practice and more theory
por: Yabe, Daisuke, et al.
Publicado: (2019)

Diabetic kidney disease: Its current trends and future therapeutic perspectives
por: Koya, Daisuke
Publicado: (2019)

A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
por: Hotta, Nigishi
Publicado: (2019)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
por: Himeno, Tatsuhito, et al.
Publicado: (2019)

Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
por: Fujita, Yoshihito, et al.
Publicado: (2019)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Recent updates and future perspectives on gestational diabetes mellitus: An important public health challenge
por: Chu, Leo Check Hei, et al.
Publicado: (2021)

Blood glucose control: Where are we?
por: Lee, Moon‐Kyu
Publicado: (2021)

Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches
por: Aso, Yoshimasa
Publicado: (2021)

Cardiovascular disease in patients with type 2 diabetes
por: Jeon, Ja Young, et al.
Publicado: (2022)

New prospects for incretin‐related drugs in the treatment of type 2 diabetes
por: Kimura, Tomohiko, et al.
Publicado: (2020)

Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
por: Nakamura, Toshihiro, et al.
Publicado: (2020)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Effects of nutrient metabolism on pancreatic β‐cell mass and function: Recent findings
por: Yasuda, Takuma, et al.
Publicado: (2023)

Evidence and implications of abnormal predictive coding in dementia
por: Kocagoncu, Ece, et al.
Publicado: (2021)

Fgl2: link between hepatitis B and SARS?
por: Robertson, Morag
Publicado: (2003)

Inceptor intercepts insulin signaling in pancreatic β‐cells
por: Watada, Hirotaka
Publicado: (2021)

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
por: Betts, Matthew J, et al.
Publicado: (2019)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

Advances in insulin therapy from discovery to β‐cell replacement
por: Sakurai, Teruaki, et al.
Publicado: (2022)

Nitrile as Activating Group in the Asymmetric Bioreduction of β-Cyanoacrylic Acids Catalyzed by Ene-Reductases
por: Winkler, Christoph K, et al.
Publicado: (2014)

Corneal cross-linking versus standard care in children with keratoconus – a randomised, multicentre, observer-masked trial of efficacy and safety (KERALINK): a statistical analysis plan
por: Chowdhury, Kashfia, et al.
Publicado: (2020)

Unappreciated role of low‐density lipoprotein receptor‐related protein 1 in pancreatic β cells: Multiple roles of low‐density lipoprotein receptor‐related protein 1 in glucose and lipid metabolism
por: Watada, Hirotaka
Publicado: (2018)

Detailed statistical analysis plan for a cluster randomised controlled trial of the Healthy Lifestyles Programme (HeLP), a novel school-based intervention to prevent obesity in school children
por: Creanor, Siobhan, et al.
Publicado: (2016)

Update of: Subramanian et al., Increasing Contraceptive Use Among Young Married Couples in Bihar, India: Evidence From a Decade of Implementation of the PRACHAR Project
Publicado: (2018)

Statistical analysis plan for a cluster-randomised trial assessing the effectiveness of implementation of a bedside evidence-based checklist for clinical management of brain-dead potential organ donors in intensive care units: DONORS (Donation Network to Optimise Organ Recovery Study)
por: Giordani, Natalia Elis, et al.
Publicado: (2020)

Lineage-specific expansion of DNA-binding transcription factor families
por: Charoensawan, Varodom, et al.
Publicado: (2010)

Update of variants identified in the pancreatic β‐cell K(ATP) channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes
por: De Franco, Elisa, et al.
Publicado: (2020)

Recent updates in factors associated with incidence and screening of diabetic eye disease
por: Sone, Hirohito
Publicado: (2023)

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_17fvahdgn9cktf1mechfgagrbm